Global Human Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Report Description


The Global Human Vaccine Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Human Vaccine Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Human Vaccine Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Human Vaccine Market product affairs. The report is at risk of project regarding this Human Vaccine Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • CNBG
  • Changsheng Life
  • Zhifei
  • ChengDa Bio
  • Kangtai
  • SINOVAC BIOTECH
  • Hissen
  • Walvax Biotechnology
  • GSK
  • SANOFI
  • Rong An
  • NuoCheng Bio
  • Hualan Bio
  • Tiantan biological
  • Changchun Baike
  • Adimmune
  • Zhongyianke Biotech

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Human Vaccine related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Human Vaccine Market

Human Vaccine Market

Report Highlights:


The Human Vaccine Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Human Vaccine Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Human Vaccine Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Human Vaccine Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Human Vaccine marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Human Vaccine market using a bottom-up approach, wherein manufacturers value data for different type (Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Rota vaccine), of Human Vaccine market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Human Vaccine Market

Human Vaccine Market

Key Target Audience:


  • Human Vaccine market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Human Vaccine market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Human Vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Human Vaccine market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Varicella
  • Influenza
  • Polio
  • Hepatitis A
  • Rabies
  • BCG
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Rota vaccine

By end-user also classify into, the Global Human Vaccine market:


Global Human Vaccine market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Adults
  • Children

Highlights of this 2021-2027 Human Vaccine Market Report:

  • Market dynamics, Human Vaccine economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Human Vaccine industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Human Vaccine Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Human Vaccine businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Human Vaccine market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

TableofContents 1ReportOverview
1.1ResearchScope
1.2TopHumanVaccineManufacturersCovered:RankingbyRevenue
1.3MarketSegmentbyType
1.3.1GlobalHumanVaccineMarketSizebyType:2016VS2021VS2027(US$Million)
1.3.2Varicella
1.3.3Influenza
1.3.4Polio
1.3.5HepatitisA
1.3.6Rabies
1.3.7BCG
1.3.8HepatitisB
1.3.9Pertussis,Diphtheria,Tetanus
1.3.10Pneumococcal
1.3.11Rotavaccine
1.4MarketSegmentbyApplication
1.4.1GlobalHumanVaccineConsumptionbyApplication:2016VS2021VS2027
1.4.2Adults
1.4.3Children
1.5StudyObjectives
1.6YearsConsidered 2GlobalMarketPerspective
2.1GlobalHumanVaccineRevenue(2016-2027)
2.1.1GlobalHumanVaccineRevenue(2016-2027)
2.1.2GlobalHumanVaccineSales(2016-2027)
2.2HumanVaccineMarketSizeacrossKeyGeographiesWorldwide:2016VS2021VS2027
2.2.1GlobalHumanVaccineSalesbyRegions(2016-2021)
2.2.2GlobalHumanVaccineRevenuebyRegions(2016-2021)
2.3GlobalTopHumanVaccineRegions(Countries)RankingbyMarketSize
2.4HumanVaccineIndustryTrends
2.4.1HumanVaccineMarketTopTrends
2.4.2MarketDrivers
2.4.3HumanVaccineMarketChallenges 2.4.4PortersFiveForcesAnalysis
2.4.5PrimaryInterviewswithKeyHumanVaccinePlayers:ViewsforFuture 3CompetitiveLandscapebyManufacturers
3.1GlobalTopHumanVaccineManufacturersbySales(2016-2021)
3.1.1GlobalHumanVaccineSalesbyManufacturers(2016-2021)
3.1.2GlobalHumanVaccineSalesMarketSharebyManufacturers(2016-2021)
3.1.3Global5and10LargestManufacturersbyHumanVaccineSalesin2020
3.2GlobalTopManufacturersHumanVaccinebyRevenue
3.2.1GlobalHumanVaccineRevenuebyManufacturers(2016-2021)
3.2.2GlobalHumanVaccineRevenueSharebyManufacturers(2016-2021)
3.2.3GlobalHumanVaccineMarketConcentrationRatio(CR5andHHI)
3.3GlobalTopManufacturersbyCompanyType(Tier1,Tier2andTier3)(basedontheRevenueinHumanVaccineasof2020)
3.4GlobalHumanVaccineAverageSellingPrice(ASP)byManufacturers
3.5KeyManufacturersHumanVaccinePlants/FactoriesDistributionandAreaServed
3.6DateofKeyManufacturersEnterintoHumanVaccineMarket
3.7KeyManufacturersHumanVaccineProductOffered 3.8Mergers&Acquisitions,ExpansionPlans 4MarketSizebyType
4.1GlobalHumanVaccineHistoricMarketReviewbyType(2016-2021)
4.1.2GlobalHumanVaccineSalesMarketSharebyType(2016-2021)
4.1.3GlobalHumanVaccineRevenueMarketSharebyType(2016-2021)
4.1.4HumanVaccinePricebyType(2016-2021)
4.1GlobalHumanVaccineMarketEstimatesandForecastsbyType(2021-2027)
4.2.2GlobalHumanVaccineSalesForecastbyType(2021-2027)
4.2.3GlobalHumanVaccineRevenueForecastbyType(2021-2027)
4.2.4HumanVaccinePriceForecastbyType(2021-2027) 5GlobalHumanVaccineMarketSizebyApplication
5.1GlobalHumanVaccineHistoricMarketReviewbyApplication(2016-2021)
5.1.2GlobalHumanVaccineSalesMarketSharebyApplication(2016-2021)
5.1.3GlobalHumanVaccineRevenueMarketSharebyApplication(2016-2021)
5.1.4HumanVaccinePricebyApplication(2016-2021)
5.2GlobalHumanVaccineMarketEstimatesandForecastsbyApplication(2021-2027)
5.2.2GlobalHumanVaccineSalesForecastbyApplication(2021-2027)
5.2.3GlobalHumanVaccineRevenueForecastbyApplication(2021-2027)
5.2.4HumanVaccinePriceForecastbyApplication(2021-2027) 6NorthAmerica
6.1NorthAmericaHumanVaccineBreakdownDatabyCompany
6.2NorthAmericaHumanVaccineBreakdownDatabyType
6.3NorthAmericaHumanVaccineBreakdownDatabyApplication
6.4NorthAmericaHumanVaccineBreakdownDatabyCountries
6.4.1NorthAmericaHumanVaccineSalesbyCountries
6.4.2NorthAmericaHumanVaccineRevenuebyCountries
6.4.3U.S.
6.4.4Canada 7Europe
7.1EuropeHumanVaccineBreakdownDatabyCompany
7.2EuropeHumanVaccineBreakdownDatabyType
7.3EuropeHumanVaccineBreakdownDatabyApplication
7.4EuropeHumanVaccineBreakdownDatabyCountries
7.4.1EuropeHumanVaccineSalesbyCountries
7.4.2EuropeHumanVaccineRevenuebyCountries
7.4.3Germany
7.4.4France
7.4.5U.K.
7.4.6Italy
7.4.7Russia 8AsiaPacific
8.1AsiaPacificHumanVaccineBreakdownDatabyCompany
8.2AsiaPacificHumanVaccineBreakdownDatabyType
8.3AsiaPacificHumanVaccineBreakdownDatabyApplication
8.4AsiaPacificHumanVaccineBreakdownDatabyRegions
8.4.1AsiaPacificHumanVaccineSalesbyRegions
8.4.2AsiaPacificHumanVaccineRevenuebyRegions
8.4.3China
8.4.4Japan
8.4.5SouthKorea
8.4.6India
8.4.7Australia
8.4.8Taiwan
8.4.9Indonesia
8.4.10Thailand
8.4.11Malaysia
8.4.12Philippines
8.4.13Vietnam 9LatinAmerica
9.1LatinAmericaHumanVaccineBreakdownDatabyCompany
9.2LatinAmericaHumanVaccineBreakdownDatabyType
9.3LatinAmericaHumanVaccineBreakdownDatabyApplication
9.4LatinAmericaHumanVaccineBreakdownDatabyCountries
9.4.1LatinAmericaHumanVaccineSalesbyCountries
9.4.2LatinAmericaHumanVaccineRevenuebyCountries
9.4.3Mexico
9.4.4Brazil
9.4.5Argentina 10MiddleEastandAfrica
10.1MiddleEastandAfricaHumanVaccineBreakdownDatabyType
10.2MiddleEastandAfricaHumanVaccineBreakdownDatabyApplication
10.3MiddleEastandAfricaHumanVaccineBreakdownDatabyCountries
10.3.1MiddleEastandAfricaHumanVaccineSalesbyCountries
10.3.2MiddleEastandAfricaHumanVaccineRevenuebyCountries
10.3.3Turkey
10.3.4SaudiArabia
10.3.5U.A.E 11CompanyProfiles
11.1CNBG
11.1.1CNBGCorporationInformation
11.1.2CNBGBusinessOverviewandTotalRevenue(2020VS2018)
11.1.3CNBGHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.1.4CNBGHumanVaccineProductsandServices
11.1.5CNBGSWOTAnalysis
11.1.6CNBGRecentDevelopments
11.2ChangshengLife
11.2.1ChangshengLifeCorporationInformation
11.2.2ChangshengLifeBusinessOverviewandTotalRevenue(2020VS2018)
11.2.3ChangshengLifeHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.2.4ChangshengLifeHumanVaccineProductsandServices
11.2.5ChangshengLifeSWOTAnalysis
11.2.6ChangshengLifeRecentDevelopments
11.3Zhifei
11.3.1ZhifeiCorporationInformation
11.3.2ZhifeiBusinessOverviewandTotalRevenue(2020VS2018)
11.3.3ZhifeiHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.3.4ZhifeiHumanVaccineProductsandServices
11.3.5ZhifeiSWOTAnalysis
11.3.6ZhifeiRecentDevelopments
11.4ChengDaBio
11.4.1ChengDaBioCorporationInformation
11.4.2ChengDaBioBusinessOverviewandTotalRevenue(2020VS2018)
11.4.3ChengDaBioHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.4.4ChengDaBioHumanVaccineProductsandServices
11.4.5ChengDaBioSWOTAnalysis
11.4.6ChengDaBioRecentDevelopments
11.5Kangtai
11.5.1KangtaiCorporationInformation
11.5.2KangtaiBusinessOverviewandTotalRevenue(2020VS2018)
11.5.3KangtaiHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.5.4KangtaiHumanVaccineProductsandServices
11.5.5KangtaiSWOTAnalysis
11.5.6KangtaiRecentDevelopments
11.6SINOVACBIOTECH
11.6.1SINOVACBIOTECHCorporationInformation
11.6.2SINOVACBIOTECHBusinessOverviewandTotalRevenue(2020VS2018)
11.6.3SINOVACBIOTECHHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.6.4SINOVACBIOTECHHumanVaccineProductsandServices
11.6.5SINOVACBIOTECHSWOTAnalysis
11.6.6SINOVACBIOTECHRecentDevelopments
11.7Hissen
11.7.1HissenCorporationInformation
11.7.2HissenBusinessOverviewandTotalRevenue(2020VS2018)
11.7.3HissenHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.7.4HissenHumanVaccineProductsandServices
11.7.5HissenSWOTAnalysis
11.7.6HissenRecentDevelopments
11.8WalvaxBiotechnology
11.8.1WalvaxBiotechnologyCorporationInformation
11.8.2WalvaxBiotechnologyBusinessOverviewandTotalRevenue(2020VS2018)
11.8.3WalvaxBiotechnologyHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.8.4WalvaxBiotechnologyHumanVaccineProductsandServices
11.8.5WalvaxBiotechnologySWOTAnalysis
11.8.6WalvaxBiotechnologyRecentDevelopments
11.9GSK
11.9.1GSKCorporationInformation
11.9.2GSKBusinessOverviewandTotalRevenue(2020VS2018)
11.9.3GSKHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.9.4GSKHumanVaccineProductsandServices
11.9.5GSKSWOTAnalysis
11.9.6GSKRecentDevelopments
11.10SANOFI
11.10.1SANOFICorporationInformation
11.10.2SANOFIBusinessOverviewandTotalRevenue(2020VS2018)
11.10.3SANOFIHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.10.4SANOFIHumanVaccineProductsandServices
11.10.5SANOFISWOTAnalysis
11.10.6SANOFIRecentDevelopments
11.11RongAn
11.11.1RongAnCorporationInformation
11.11.2RongAnBusinessOverviewandTotalRevenue(2020VS2018)
11.11.3RongAnHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.11.4RongAnHumanVaccineProductsandServices
11.11.5RongAnSWOTAnalysis
11.11.6RongAnRecentDevelopments
11.12NuoChengBio
11.12.1NuoChengBioCorporationInformation
11.12.2NuoChengBioBusinessOverviewandTotalRevenue(2020VS2018)
11.12.3NuoChengBioHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.12.4NuoChengBioHumanVaccineProductsandServices
11.12.5NuoChengBioSWOTAnalysis
11.12.6NuoChengBioRecentDevelopments
11.13HualanBio
11.13.1HualanBioCorporationInformation
11.13.2HualanBioBusinessOverviewandTotalRevenue(2020VS2018)
11.13.3HualanBioHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.13.4HualanBioHumanVaccineProductsandServices
11.13.5HualanBioSWOTAnalysis
11.13.6HualanBioRecentDevelopments
11.14Tiantanbiological
11.14.1TiantanbiologicalCorporationInformation
11.14.2TiantanbiologicalBusinessOverviewandTotalRevenue(2020VS2018)
11.14.3TiantanbiologicalHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.14.4TiantanbiologicalHumanVaccineProductsandServices
11.14.5TiantanbiologicalSWOTAnalysis
11.14.6TiantanbiologicalRecentDevelopments
11.15ChangchunBaike
11.15.1ChangchunBaikeCorporationInformation
11.15.2ChangchunBaikeBusinessOverviewandTotalRevenue(2020VS2018)
11.15.3ChangchunBaikeHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.15.4ChangchunBaikeHumanVaccineProductsandServices
11.15.5ChangchunBaikeSWOTAnalysis
11.15.6ChangchunBaikeRecentDevelopments
11.16Adimmune
11.16.1AdimmuneCorporationInformation
11.16.2AdimmuneBusinessOverviewandTotalRevenue(2020VS2018)
11.16.3AdimmuneHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.16.4AdimmuneHumanVaccineProductsandServices
11.16.5AdimmuneSWOTAnalysis
11.16.6AdimmuneRecentDevelopments
11.17ZhongyiankeBiotech
11.17.1ZhongyiankeBiotechCorporationInformation
11.17.2ZhongyiankeBiotechBusinessOverviewandTotalRevenue(2020VS2018)
11.17.3ZhongyiankeBiotechHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.17.4ZhongyiankeBiotechHumanVaccineProductsandServices
11.17.5ZhongyiankeBiotechSWOTAnalysis
11.17.6ZhongyiankeBiotechRecentDevelopments 12SupplyChainandSalesChannelsAnalysis 12.1SupplyChainAnalysis 12.2SalesChannelsAnalysis
12.2.1HumanVaccineSalesChannels
12.2.2HumanVaccineDistributors
12.3HumanVaccineCustomers 13EstimatesandProjectionsbyRegions(2021-2027)
13.1GlobalHumanVaccineSalesForecast(2021-2027)
13.1.1GlobalHumanVaccineSalesForecastbyRegions(2021-2027)
13.1.2GlobalHumanVaccineRevenueForecastbyRegions(2021-2027) 13.2NorthAmericaMarketSizeForecast(2021-2027)
13.2.1NorthAmericaHumanVaccineSalesForecast(2021-2027)
13.2.2NorthAmericaHumanVaccineRevenueForecast(2021-2027)
13.2.3NorthAmericaHumanVaccineSizeForecastbyCounty(2021-2027) 13.3EuropeMarketSizeForecast(2021-2027)
13.3.1EuropeHumanVaccineSalesForecast(2021-2027)
13.3.2EuropeHumanVaccineRevenueForecast(2021-2027)
13.3.3EuropeHumanVaccineSizeForecastbyCounty(2021-2027) 13.4AsiaPacificMarketSizeForecast(2021-2027)
13.4.1AsiaPacificHumanVaccineSalesForecast(2021-2027)
13.4.2AsiaPacificHumanVaccineRevenueForecast(2021-2027)
13.4.3AsiaPacificHumanVaccineSizeForecastbyRegion(2021-2027) 13.5LatinAmericaMarketSizeForecast(2021-2027)
13.5.1LatinAmericaHumanVaccineSalesForecast(2021-2027)
13.5.2LatinAmericaHumanVaccineRevenueForecast(2021-2027)
13.5.3LatinAmericaHumanVaccineSizeForecastbyCounty(2021-2027) 13.6MiddleEastandAfricaMarketForecast
13.6.1MiddleEastandAfricaHumanVaccineSalesForecast(2021-2027)
13.6.2MiddleEastandAfricaHumanVaccineRevenueForecast(2021-2027)
13.6.3MiddleEastandAfricaHumanVaccineSizeForecastbyCounty(2021-2027) 14ResearchFindingsandConclusion 15Appendix
15.1ResearchMethodology
15.1.1Methodology/ResearchApproach
15.1.2DataSource
15.2AuthorDetails
15.3Disclaimer

List of Tables
Table 1. Human Vaccine Key Market Segments
Table 2. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 3. Global Human Vaccine Market Size Growth Rate by Type 2021-2027 (M Doses) & (Million US$)
Table 4. Major Manufacturers of Varicella
Table 5. Major Manufacturers of Influenza
Table 6. Major Manufacturers of Polio
Table 7. Major Manufacturers of Hepatitis A
Table 8. Major Manufacturers of Rabies
Table 9. Major Manufacturers of BCG
Table 10. Major Manufacturers of Hepatitis B
Table 11. Major Manufacturers of Pertussis, Diphtheria, Tetanus
Table 12. Major Manufacturers of Pneumococcal
Table 13. Major Manufacturers of Rota vaccine
Table 14. Global Human Vaccine Market Share by Application 2020-2025 (M Doses)
Table 15. Global Human Vaccine Market Size by Regions 2016-2021 (M Doses) & (Million US$)
Table 16. Global Human Vaccine Sales by Regions 2016-2021 (M Doses)
Table 17. Global Human Vaccine Sales Market Share by Regions 2016-2021
Table 18. Global Human Vaccine Revenue by Regions 2016-2021 (Million US$)
Table 19. Global Human Vaccine Revenue Market Share by Regions 2016-2021
Table 20. Top Human Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2020
Table 21. Market Top Trends
Table 22. Human Vaccine Key Drivers: Impact Analysis (2021-2027)
Table 23. Human Vaccine Key Challenges
Table 24. Main Points Interviewed from Key Human Vaccine Players: Views for Future
Table 25. Global Human Vaccine Sales by Manufacturers (2016-2021) (M Doses)
Table 26. Global Human Vaccine Sales Share by Manufacturers (2016-2021)
Table 27. Human Vaccine Revenue by Manufacturers (2016-2021) (Million US$)
Table 28. Human Vaccine Revenue Share by Manufacturers (2016-2021)
Table 29. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2020)
Table 31. Key Manufacturers Human Vaccine Average Selling Price (ASP) (2016-2021) (USD/Dose)
Table 32. Key Manufacturers Human Vaccine Plants/Factories Distribution
Table 33. Key Manufacturers Human Vaccine Area Served
Table 34. Date of Key Manufacturers Enter into Human Vaccine Market
Table 35. Key Manufacturers Human Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Varicella Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 38. Global Influenza Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 39. Global Polio Sales ana Revenue (2016-2021) (M Doses) & (Million US$)
Table 40. Global Hepatitis A Sales ana Revenue (2016-2021) (M Doses) & (Million US$)
Table 41. Global Rabies Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 42. Global BCG Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 43. Global Hepatitis B Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 44. Global Pertussis, Diphtheria, Tetanus Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 45. Global Pneumococcal Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 46. Global Rota vaccine Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 47. Global Human Vaccine Sales (M Doses) by Type (2016-2021)
Table 48. Global Human Vaccine Sales Share by Type (2016-2021)
Table 49. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 50. Global Human Vaccine Price (M Doses) by Type (2016-2021)
Table 51. Global Human Vaccine Sales (M Doses) by Type (2021-2027)
Table 52. Global Human Vaccine Sales Share by Type (2021-2027)
Table 53. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2021-2027)
Table 54. Global Human Vaccine Revenue Share by Type (2021-2027)
Table 55. Global Human Vaccine Price (M Doses) by Type (2021-2027)
Table 56. Global Human Vaccine Sales (M Doses) by Application (2016-2021)
Table 57. Global Human Vaccine Sales Share by Application (2016-2021)
Table 58. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 59. Global Human Vaccine Price by Application 2016-2021 (USD/Dose)
Table 60. Global Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 61. Global Human Vaccine Sales Share by Application (2016-2021)
Table 62. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2021-2027)
Table 63. Global Human Vaccine Revenue Share by Application (2021-2027)
Table 64. Global Human Vaccine Price (M Doses) by Application (2021-2027)
Table 65. North America Human Vaccine Sales by Company (2016-2021) (M Doses)
Table 66. North America Human Vaccine Sales Market Share by Company (2016-2021)
Table 67. North America Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 68. North America Human Vaccine Sales Market Share by Type (2016-2021)
Table 69. North America Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 70. North America Human Vaccine Sales Market Share by Application (2016-2021)
Table 71. North America Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 72. North America Human Vaccine Sales Market Share by Countries (2016-2021)
Table 73. North America Human Vaccine Revenue by Countries (2016-2021) (Million US$)
Table 74. North America Human Vaccine Revenue Market Share by Countries (2016-2021)
Table 75. Europe Human Vaccine Sales by Company (2016-2021) (M Doses)
Table 76. Europe Human Vaccine Sales Market Share by Company (2016-2021)
Table 77. Europe Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 78. Europe Human Vaccine Sales Market Share by Type (2016-2021)
Table 79. Europe Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 80. Europe Human Vaccine Sales Market Share by Application (2016-2021)
Table 81. Europe Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 82. Europe Human Vaccine Sales Market Share by Countries (2016-2021)
Table 83. Europe Human Vaccine Revenue by Countries (2016-2021) (Million US$)
Table 84. Europe Human Vaccine Revenue Market Share by Countries (2016-2021)
Table 85. Asia Pacific Human Vaccine Sales by Regions (2016-2021) (M Doses)
Table 86. Asia Pacific Human Vaccine Sales Market Share by Regions (2016-2021)
Table 87. Asia Pacific Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 88. Asia Pacific Human Vaccine Sales Market Share by Type (2016-2021)
Table 89. Asia Pacific Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 90. Asia Pacific Human Vaccine Sales Market Share by Application (2016-2021)
Table 91. Asia Pacific Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 92. Asia Pacific Human Vaccine Sales Market Share by Regions (2016-2021)
Table 93. Asia Pacific Human Vaccine Revenue by Regions (2016-2021) (Million US$)
Table 94. Asia Pacific Human Vaccine Revenue Market Share by Regions (2016-2021)
Table 95. Latin America Human Vaccine Sales by Company (2016-2021) (M Doses)
Table 96. Latin America Human Vaccine Sales Market Share by Company (2016-2021)
Table 97. Latin America Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 98. Latin America Human Vaccine Sales Market Share by Type (2016-2021)
Table 99. Latin America Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 100. Latin America Human Vaccine Sales Market Share by Application (2016-2021)
Table 101. Latin America Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 102. Latin America Human Vaccine Sales Market Share by Countries (2016-2021)
Table 103. Latin America Human Vaccine Revenue by Countries (2016-2021) (Million US$)
Table 104. Latin America Human Vaccine Revenue Market Share by Countries (2016-2021)
Table 105. Middle East and Africa Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 106. Middle East and Africa Human Vaccine Sales Market Share by Type (2016-2021)
Table 107. Middle East and Africa Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 108. Middle East and Africa Human Vaccine Sales Market Share by Application (2016-2021)
Table 109. Middle East and Africa Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 110. Middle East and Africa Human Vaccine Sales Market Share by Countries (2016-2021)
Table 111. Middle East and Africa Human Vaccine Revenue by Countries (2016-2021) (Million US$)
Table 112. Middle East and Africa Human Vaccine Revenue Market Share by Countries (2016-2021)
Table 113. CNBG Company Details
Table 114. CNBG Description and Business Overview
Table 115. CNBG Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. CNBG Human Vaccine Sales Growth Rate (2016-2021)
Table 117. CNBG Human Vaccine Sales Market Share in Global Market
Table 118. CNBG Recent Development
Table 119. Changsheng Life Company Details
Table 120. Changsheng Life Description and Business Overview
Table 121. Changsheng Life Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 122. Changsheng Life Human Vaccine Sales Growth Rate (2016-2021)
Table 123. Changsheng Life Human Vaccine Sales Market Share in Global Market
Table 124. Changsheng Life Recent Development
Table 125. Zhifei Company Details
Table 126. Zhifei Description and Business Overview
Table 127. Zhifei Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Zhifei Human Vaccine Sales Growth Rate (2016-2021)
Table 129. Zhifei Human Vaccine Sales Market Share in Global Market
Table 130. Zhifei Recent Development
Table 131. ChengDa Bio Company Details
Table 132. ChengDa Bio Description and Business Overview
Table 133. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 134. ChengDa Bio Human Vaccine Sales Growth Rate (2016-2021)
Table 135. ChengDa Bio Human Vaccine Sales Market Share in Global Market
Table 136. ChengDa Bio Recent Development
Table 137. Kangtai Company Details
Table 138. Kangtai Description and Business Overview
Table 139. Kangtai Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 140. Kangtai Human Vaccine Sales Growth Rate (2016-2021)
Table 141. Kangtai Human Vaccine Sales Market Share in Global Market
Table 142. Kangtai Recent Development
Table 143. SINOVAC BIOTECH Company Details
Table 144. SINOVAC BIOTECH Description and Business Overview
Table 145. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 146. SINOVAC BIOTECH Human Vaccine Sales Growth Rate (2016-2021)
Table 147. SINOVAC BIOTECH Human Vaccine Sales Market Share in Global Market
Table 148. SINOVAC BIOTECH Recent Development
Table 149. Hissen Company Details
Table 150. Hissen Description and Business Overview
Table 151. Hissen Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. Hissen Human Vaccine Sales Growth Rate (2016-2021)
Table 153. Hissen Human Vaccine Sales Market Share in Global Market
Table 154. Hissen Recent Development
Table 155. Walvax Biotechnology Company Details
Table 156. Walvax Biotechnology Description and Business Overview
Table 157. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Walvax Biotechnology Human Vaccine Sales Growth Rate (2016-2021)
Table 159. Walvax Biotechnology Human Vaccine Sales Market Share in Global Market
Table 160. Walvax Biotechnology Recent Development
Table 161. GSK Company Details
Table 162. GSK Description and Business Overview
Table 163. GSK Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 164. GSK Human Vaccine Sales Growth Rate (2016-2021)
Table 165. GSK Human Vaccine Sales Market Share in Global Market
Table 166. GSK Recent Development
Table 167. SANOFI Company Details
Table 168. SANOFI Description and Business Overview
Table 169. SANOFI Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 170. SANOFI Human Vaccine Sales Growth Rate (2016-2021)
Table 171. SANOFI Human Vaccine Sales Market Share in Global Market
Table 172. SANOFI Recent Development
Table 173. Rong An Company Details
Table 174. Rong An Description and Business Overview
Table 175. Rong An Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 176. Rong An Human Vaccine Sales Growth Rate (2016-2021)
Table 177. Rong An Human Vaccine Sales Market Share in Global Market
Table 178. Rong An Recent Development
Table 179. NuoCheng Bio Company Details
Table 180. NuoCheng Bio Description and Business Overview
Table 181. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 182. NuoCheng Bio Human Vaccine Sales Growth Rate (2016-2021)
Table 183. NuoCheng Bio Human Vaccine Sales Market Share in Global Market
Table 184. NuoCheng Bio Recent Development
Table 185. Hualan Bio Company Details
Table 186. Hualan Bio Description and Business Overview
Table 187. Hualan Bio Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 188. Hualan Bio Human Vaccine Sales Growth Rate (2016-2021)
Table 189. Hualan Bio Human Vaccine Sales Market Share in Global Market
Table 190. Hualan Bio Recent Development
Table 191. Tiantan biological Company Details
Table 192. Tiantan biological Description and Business Overview
Table 193. Tiantan biological Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 194. Tiantan biological Human Vaccine Sales Growth Rate (2016-2021)
Table 195. Tiantan biological Human Vaccine Sales Market Share in Global Market
Table 196. Tiantan biological Recent Development
Table 197. Changchun Baike Company Details
Table 198. Changchun Baike Description and Business Overview
Table 199. Changchun Baike Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 200. Changchun Baike Human Vaccine Sales Growth Rate (2016-2021)
Table 201. Changchun Baike Human Vaccine Sales Market Share in Global Market
Table 202. Changchun Baike Recent Development
Table 203. Adimmune Company Details
Table 204. Adimmune Description and Business Overview
Table 205. Adimmune Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 206. Adimmune Human Vaccine Sales Growth Rate (2016-2021)
Table 207. Adimmune Human Vaccine Sales Market Share in Global Market
Table 208. Adimmune Recent Development
Table 209. Zhongyianke Biotech Company Details
Table 210. Zhongyianke Biotech Description and Business Overview
Table 211. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 212. Zhongyianke Biotech Human Vaccine Sales Growth Rate (2016-2021)
Table 213. Zhongyianke Biotech Human Vaccine Sales Market Share in Global Market
Table 214. Zhongyianke Biotech Recent Development
Table 215. Human Vaccine Distributors List
Table 216. Human Vaccine Customers List
Table 217. Global Human Vaccine Sales Forecast 2021-2027 (M Doses) & (Million US$)
Table 218. Global Human Vaccine Sales Forecast by Type 2021-2027 (M Doses)
Table 219. Global Human Vaccine Sales Forecast by Application 2021-2027 (M Doses)
Table 220. Global Human Vaccine Sales Forecast by Regions 2021-2027 (M Doses)
Table 221. Global Human Vaccine Revenue Forecast by Regions 2021-2027 (Million US$)
Table 222. North America Human Vaccine Sales Forecast by Countries 2021-2027 (M Doses)
Table 223. North America Human Vaccine Revenue Forecast by Countries 2021-2027
Table 224. Europe Human Vaccine Sales Forecast by Countries 2021-2027 (M Doses)
Table 225. Europe Human Vaccine Revenue Market Share Forecast by Countries 2021-2027
Table 226. Asia Pacific Human Vaccine Sales Forecast by Regions 2021-2027 (M Doses)
Table 227. Asia Pacific Human Vaccine Revenue Forecast by Regions 2021-2027 (Million US$)
Table 228. Latin America Human Vaccine Sales Forecast by Countries 2021-2027 (M Doses)
Table 229. Latin America Human Vaccine Revenue Forecast by Countries 2021-2027 (Million US$)
Table 230. Middle East and Africa Human Vaccine Sales Forecast by Regions 2021-2027 (M Doses)
Table 231. Middle East and Africa Human Vaccine Revenue Forecast by Regions 2021-2027 (Million US$)
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Vaccine Product Picture
Figure 2. Global Human Vaccine Sales Market Shar by Type 2016-2027
Figure 3. Varicella Figures
Figure 4. Influenza Figures
Figure 5. Polio Figures
Figure 6. Hepatitis A Figures
Figure 7. Rabies Figures
Figure 8. BCG Figures
Figure 9. Hepatitis B Figures
Figure 10. Pertussis, Diphtheria, Tetanus Figures
Figure 11. Pneumococcal Figures
Figure 12. Global Human Vaccine Sales Market Share by Application in 2020 & 2027
Figure 13. Adults Use Case
Figure 14. Children Use Case
Figure 15. Human Vaccine Report Years Considered
Figure 16. Global Human Vaccine Market Size 2016-2027 (Million US$)
Figure 17. Global Human Vaccine Sales 2016-2021 (M Doses)
Figure 18. Global Human Vaccine Market Size Market Share by Regions 2016-2021
Figure 19. Global Human Vaccine Sales Market Share by Regions in 2020
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Human Vaccine Sales Share by Manufacturers in 2020
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Vaccine Sales in 2020
Figure 23. Human Vaccine Value Share by Manufacturers in 2020
Figure 24. Human Vaccine Revenue Share by Manufacturers In 2020
Figure 25. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Human Vaccine Revenue Share by Type (2016-2021)
Figure 27. Global Human Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 28. Global Human Vaccine Market Share by Price Range (2016-2021)
Figure 29. Global Human Vaccine Revenue Share by Application (2016-2021)
Figure 30. Global Human Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 31. North America Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 32. U.S. Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 33. Canada Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 34. Europe Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 35. Germany Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 36. France Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 37. U.K. Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 38. Italy Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 39. Russia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 40. Asia Pacific Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 41. China Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 42. Japan Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 43. South Korea Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 44. India Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 45. Australia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 46. Taiwan Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 47. Indonesia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 48. Thailand Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 49. Malaysia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 50. Philippines Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 51. Vietnam Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 52. Latin America Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 53. Mexico Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 54. Brazil Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 55. Argentina Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 56. Middle East and Africa Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 57. Turkey Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 58. Saudi Arabia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 59. U.A.E Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 60. CNBG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 61. Changsheng Life Total Revenue (US$ Million): 2020 Compared with 2018
Figure 62. Zhifei Total Revenue (US$ Million): 2020 Compared with 2018
Figure 63. ChengDa Bio Total Revenue (US$ Million): 2020 Compared with 2018
Figure 64. Kangtai Total Revenue (US$ Million): 2020 Compared with 2018
Figure 65. SINOVAC BIOTECH Total Revenue (US$ Million): 2020 Compared with 2018
Figure 66. Hissen Total Revenue (US$ Million): 2020 Compared with 2018
Figure 67. Walvax Biotechnology Total Revenue (US$ Million): 2020 Compared with 2018
Figure 68. GSK Total Revenue (US$ Million): 2020 Compared with 2018
Figure 69. SANOFI Total Revenue (US$ Million): 2020 Compared with 2018
Figure 70. Rong An Total Revenue (US$ Million): 2020 Compared with 2018
Figure 71. NuoCheng Bio Total Revenue (US$ Million): 2020 Compared with 2018
Figure 72. Hualan Bio Total Revenue (US$ Million): 2020 Compared with 2018
Figure 73. Tiantan biological Total Revenue (US$ Million): 2020 Compared with 2018
Figure 74. Changchun Baike Total Revenue (US$ Million): 2020 Compared with 2018
Figure 75. Adimmune Total Revenue (US$ Million): 2020 Compared with 2018
Figure 76. Zhongyianke Biotech Total Revenue (US$ Million): 2020 Compared with 2018
Figure 77. Human Vaccine Value Chain
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. North America Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 81. North America Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 82. Europe Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 83. Europe Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 84. Asia Pacific Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 85. Asia Pacific Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 86. Latin America Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 87. Latin America Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 88. Middle East and Africa Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 89. Middle East and Africa Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

Human Vaccine Market Segments


Human Vaccine Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Varicella
  • Influenza
  • Polio
  • Hepatitis A
  • Rabies
  • BCG
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Rota vaccine

Human Vaccine Application Outlook (Revenue, USD Million, 2021 2027)


  • Adults
  • Children

Human Vaccine Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

  • Europe
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

  • Asia Pacific
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

  • Latin America
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

  • Middle East & Africa
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Human Vaccine Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Human Vaccine Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Human Vaccine Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Human Vaccine Market product affairs. The report is at risk of project regarding this Human Vaccine Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • CNBG
  • Changsheng Life
  • Zhifei
  • ChengDa Bio
  • Kangtai
  • SINOVAC BIOTECH
  • Hissen
  • Walvax Biotechnology
  • GSK
  • SANOFI
  • Rong An
  • NuoCheng Bio
  • Hualan Bio
  • Tiantan biological
  • Changchun Baike
  • Adimmune
  • Zhongyianke Biotech

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Human Vaccine related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Human Vaccine Market

Human Vaccine Market

Report Highlights:


The Human Vaccine Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Human Vaccine Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Human Vaccine Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Human Vaccine Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Human Vaccine marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Human Vaccine market using a bottom-up approach, wherein manufacturers value data for different type (Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Rota vaccine), of Human Vaccine market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Human Vaccine Market

Human Vaccine Market

Key Target Audience:


  • Human Vaccine market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Human Vaccine market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Human Vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Human Vaccine market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Varicella
  • Influenza
  • Polio
  • Hepatitis A
  • Rabies
  • BCG
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Rota vaccine

By end-user also classify into, the Global Human Vaccine market:


Global Human Vaccine market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Adults
  • Children

Highlights of this 2021-2027 Human Vaccine Market Report:

  • Market dynamics, Human Vaccine economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Human Vaccine industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Human Vaccine Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Human Vaccine businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Human Vaccine market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
TableofContents 1ReportOverview
1.1ResearchScope
1.2TopHumanVaccineManufacturersCovered:RankingbyRevenue
1.3MarketSegmentbyType
1.3.1GlobalHumanVaccineMarketSizebyType:2016VS2021VS2027(US$Million)
1.3.2Varicella
1.3.3Influenza
1.3.4Polio
1.3.5HepatitisA
1.3.6Rabies
1.3.7BCG
1.3.8HepatitisB
1.3.9Pertussis,Diphtheria,Tetanus
1.3.10Pneumococcal
1.3.11Rotavaccine
1.4MarketSegmentbyApplication
1.4.1GlobalHumanVaccineConsumptionbyApplication:2016VS2021VS2027
1.4.2Adults
1.4.3Children
1.5StudyObjectives
1.6YearsConsidered 2GlobalMarketPerspective
2.1GlobalHumanVaccineRevenue(2016-2027)
2.1.1GlobalHumanVaccineRevenue(2016-2027)
2.1.2GlobalHumanVaccineSales(2016-2027)
2.2HumanVaccineMarketSizeacrossKeyGeographiesWorldwide:2016VS2021VS2027
2.2.1GlobalHumanVaccineSalesbyRegions(2016-2021)
2.2.2GlobalHumanVaccineRevenuebyRegions(2016-2021)
2.3GlobalTopHumanVaccineRegions(Countries)RankingbyMarketSize
2.4HumanVaccineIndustryTrends
2.4.1HumanVaccineMarketTopTrends
2.4.2MarketDrivers
2.4.3HumanVaccineMarketChallenges 2.4.4PortersFiveForcesAnalysis
2.4.5PrimaryInterviewswithKeyHumanVaccinePlayers:ViewsforFuture 3CompetitiveLandscapebyManufacturers
3.1GlobalTopHumanVaccineManufacturersbySales(2016-2021)
3.1.1GlobalHumanVaccineSalesbyManufacturers(2016-2021)
3.1.2GlobalHumanVaccineSalesMarketSharebyManufacturers(2016-2021)
3.1.3Global5and10LargestManufacturersbyHumanVaccineSalesin2020
3.2GlobalTopManufacturersHumanVaccinebyRevenue
3.2.1GlobalHumanVaccineRevenuebyManufacturers(2016-2021)
3.2.2GlobalHumanVaccineRevenueSharebyManufacturers(2016-2021)
3.2.3GlobalHumanVaccineMarketConcentrationRatio(CR5andHHI)
3.3GlobalTopManufacturersbyCompanyType(Tier1,Tier2andTier3)(basedontheRevenueinHumanVaccineasof2020)
3.4GlobalHumanVaccineAverageSellingPrice(ASP)byManufacturers
3.5KeyManufacturersHumanVaccinePlants/FactoriesDistributionandAreaServed
3.6DateofKeyManufacturersEnterintoHumanVaccineMarket
3.7KeyManufacturersHumanVaccineProductOffered 3.8Mergers&Acquisitions,ExpansionPlans 4MarketSizebyType
4.1GlobalHumanVaccineHistoricMarketReviewbyType(2016-2021)
4.1.2GlobalHumanVaccineSalesMarketSharebyType(2016-2021)
4.1.3GlobalHumanVaccineRevenueMarketSharebyType(2016-2021)
4.1.4HumanVaccinePricebyType(2016-2021)
4.1GlobalHumanVaccineMarketEstimatesandForecastsbyType(2021-2027)
4.2.2GlobalHumanVaccineSalesForecastbyType(2021-2027)
4.2.3GlobalHumanVaccineRevenueForecastbyType(2021-2027)
4.2.4HumanVaccinePriceForecastbyType(2021-2027) 5GlobalHumanVaccineMarketSizebyApplication
5.1GlobalHumanVaccineHistoricMarketReviewbyApplication(2016-2021)
5.1.2GlobalHumanVaccineSalesMarketSharebyApplication(2016-2021)
5.1.3GlobalHumanVaccineRevenueMarketSharebyApplication(2016-2021)
5.1.4HumanVaccinePricebyApplication(2016-2021)
5.2GlobalHumanVaccineMarketEstimatesandForecastsbyApplication(2021-2027)
5.2.2GlobalHumanVaccineSalesForecastbyApplication(2021-2027)
5.2.3GlobalHumanVaccineRevenueForecastbyApplication(2021-2027)
5.2.4HumanVaccinePriceForecastbyApplication(2021-2027) 6NorthAmerica
6.1NorthAmericaHumanVaccineBreakdownDatabyCompany
6.2NorthAmericaHumanVaccineBreakdownDatabyType
6.3NorthAmericaHumanVaccineBreakdownDatabyApplication
6.4NorthAmericaHumanVaccineBreakdownDatabyCountries
6.4.1NorthAmericaHumanVaccineSalesbyCountries
6.4.2NorthAmericaHumanVaccineRevenuebyCountries
6.4.3U.S.
6.4.4Canada 7Europe
7.1EuropeHumanVaccineBreakdownDatabyCompany
7.2EuropeHumanVaccineBreakdownDatabyType
7.3EuropeHumanVaccineBreakdownDatabyApplication
7.4EuropeHumanVaccineBreakdownDatabyCountries
7.4.1EuropeHumanVaccineSalesbyCountries
7.4.2EuropeHumanVaccineRevenuebyCountries
7.4.3Germany
7.4.4France
7.4.5U.K.
7.4.6Italy
7.4.7Russia 8AsiaPacific
8.1AsiaPacificHumanVaccineBreakdownDatabyCompany
8.2AsiaPacificHumanVaccineBreakdownDatabyType
8.3AsiaPacificHumanVaccineBreakdownDatabyApplication
8.4AsiaPacificHumanVaccineBreakdownDatabyRegions
8.4.1AsiaPacificHumanVaccineSalesbyRegions
8.4.2AsiaPacificHumanVaccineRevenuebyRegions
8.4.3China
8.4.4Japan
8.4.5SouthKorea
8.4.6India
8.4.7Australia
8.4.8Taiwan
8.4.9Indonesia
8.4.10Thailand
8.4.11Malaysia
8.4.12Philippines
8.4.13Vietnam 9LatinAmerica
9.1LatinAmericaHumanVaccineBreakdownDatabyCompany
9.2LatinAmericaHumanVaccineBreakdownDatabyType
9.3LatinAmericaHumanVaccineBreakdownDatabyApplication
9.4LatinAmericaHumanVaccineBreakdownDatabyCountries
9.4.1LatinAmericaHumanVaccineSalesbyCountries
9.4.2LatinAmericaHumanVaccineRevenuebyCountries
9.4.3Mexico
9.4.4Brazil
9.4.5Argentina 10MiddleEastandAfrica
10.1MiddleEastandAfricaHumanVaccineBreakdownDatabyType
10.2MiddleEastandAfricaHumanVaccineBreakdownDatabyApplication
10.3MiddleEastandAfricaHumanVaccineBreakdownDatabyCountries
10.3.1MiddleEastandAfricaHumanVaccineSalesbyCountries
10.3.2MiddleEastandAfricaHumanVaccineRevenuebyCountries
10.3.3Turkey
10.3.4SaudiArabia
10.3.5U.A.E 11CompanyProfiles
11.1CNBG
11.1.1CNBGCorporationInformation
11.1.2CNBGBusinessOverviewandTotalRevenue(2020VS2018)
11.1.3CNBGHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.1.4CNBGHumanVaccineProductsandServices
11.1.5CNBGSWOTAnalysis
11.1.6CNBGRecentDevelopments
11.2ChangshengLife
11.2.1ChangshengLifeCorporationInformation
11.2.2ChangshengLifeBusinessOverviewandTotalRevenue(2020VS2018)
11.2.3ChangshengLifeHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.2.4ChangshengLifeHumanVaccineProductsandServices
11.2.5ChangshengLifeSWOTAnalysis
11.2.6ChangshengLifeRecentDevelopments
11.3Zhifei
11.3.1ZhifeiCorporationInformation
11.3.2ZhifeiBusinessOverviewandTotalRevenue(2020VS2018)
11.3.3ZhifeiHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.3.4ZhifeiHumanVaccineProductsandServices
11.3.5ZhifeiSWOTAnalysis
11.3.6ZhifeiRecentDevelopments
11.4ChengDaBio
11.4.1ChengDaBioCorporationInformation
11.4.2ChengDaBioBusinessOverviewandTotalRevenue(2020VS2018)
11.4.3ChengDaBioHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.4.4ChengDaBioHumanVaccineProductsandServices
11.4.5ChengDaBioSWOTAnalysis
11.4.6ChengDaBioRecentDevelopments
11.5Kangtai
11.5.1KangtaiCorporationInformation
11.5.2KangtaiBusinessOverviewandTotalRevenue(2020VS2018)
11.5.3KangtaiHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.5.4KangtaiHumanVaccineProductsandServices
11.5.5KangtaiSWOTAnalysis
11.5.6KangtaiRecentDevelopments
11.6SINOVACBIOTECH
11.6.1SINOVACBIOTECHCorporationInformation
11.6.2SINOVACBIOTECHBusinessOverviewandTotalRevenue(2020VS2018)
11.6.3SINOVACBIOTECHHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.6.4SINOVACBIOTECHHumanVaccineProductsandServices
11.6.5SINOVACBIOTECHSWOTAnalysis
11.6.6SINOVACBIOTECHRecentDevelopments
11.7Hissen
11.7.1HissenCorporationInformation
11.7.2HissenBusinessOverviewandTotalRevenue(2020VS2018)
11.7.3HissenHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.7.4HissenHumanVaccineProductsandServices
11.7.5HissenSWOTAnalysis
11.7.6HissenRecentDevelopments
11.8WalvaxBiotechnology
11.8.1WalvaxBiotechnologyCorporationInformation
11.8.2WalvaxBiotechnologyBusinessOverviewandTotalRevenue(2020VS2018)
11.8.3WalvaxBiotechnologyHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.8.4WalvaxBiotechnologyHumanVaccineProductsandServices
11.8.5WalvaxBiotechnologySWOTAnalysis
11.8.6WalvaxBiotechnologyRecentDevelopments
11.9GSK
11.9.1GSKCorporationInformation
11.9.2GSKBusinessOverviewandTotalRevenue(2020VS2018)
11.9.3GSKHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.9.4GSKHumanVaccineProductsandServices
11.9.5GSKSWOTAnalysis
11.9.6GSKRecentDevelopments
11.10SANOFI
11.10.1SANOFICorporationInformation
11.10.2SANOFIBusinessOverviewandTotalRevenue(2020VS2018)
11.10.3SANOFIHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.10.4SANOFIHumanVaccineProductsandServices
11.10.5SANOFISWOTAnalysis
11.10.6SANOFIRecentDevelopments
11.11RongAn
11.11.1RongAnCorporationInformation
11.11.2RongAnBusinessOverviewandTotalRevenue(2020VS2018)
11.11.3RongAnHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.11.4RongAnHumanVaccineProductsandServices
11.11.5RongAnSWOTAnalysis
11.11.6RongAnRecentDevelopments
11.12NuoChengBio
11.12.1NuoChengBioCorporationInformation
11.12.2NuoChengBioBusinessOverviewandTotalRevenue(2020VS2018)
11.12.3NuoChengBioHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.12.4NuoChengBioHumanVaccineProductsandServices
11.12.5NuoChengBioSWOTAnalysis
11.12.6NuoChengBioRecentDevelopments
11.13HualanBio
11.13.1HualanBioCorporationInformation
11.13.2HualanBioBusinessOverviewandTotalRevenue(2020VS2018)
11.13.3HualanBioHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.13.4HualanBioHumanVaccineProductsandServices
11.13.5HualanBioSWOTAnalysis
11.13.6HualanBioRecentDevelopments
11.14Tiantanbiological
11.14.1TiantanbiologicalCorporationInformation
11.14.2TiantanbiologicalBusinessOverviewandTotalRevenue(2020VS2018)
11.14.3TiantanbiologicalHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.14.4TiantanbiologicalHumanVaccineProductsandServices
11.14.5TiantanbiologicalSWOTAnalysis
11.14.6TiantanbiologicalRecentDevelopments
11.15ChangchunBaike
11.15.1ChangchunBaikeCorporationInformation
11.15.2ChangchunBaikeBusinessOverviewandTotalRevenue(2020VS2018)
11.15.3ChangchunBaikeHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.15.4ChangchunBaikeHumanVaccineProductsandServices
11.15.5ChangchunBaikeSWOTAnalysis
11.15.6ChangchunBaikeRecentDevelopments
11.16Adimmune
11.16.1AdimmuneCorporationInformation
11.16.2AdimmuneBusinessOverviewandTotalRevenue(2020VS2018)
11.16.3AdimmuneHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.16.4AdimmuneHumanVaccineProductsandServices
11.16.5AdimmuneSWOTAnalysis
11.16.6AdimmuneRecentDevelopments
11.17ZhongyiankeBiotech
11.17.1ZhongyiankeBiotechCorporationInformation
11.17.2ZhongyiankeBiotechBusinessOverviewandTotalRevenue(2020VS2018)
11.17.3ZhongyiankeBiotechHumanVaccineSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.17.4ZhongyiankeBiotechHumanVaccineProductsandServices
11.17.5ZhongyiankeBiotechSWOTAnalysis
11.17.6ZhongyiankeBiotechRecentDevelopments 12SupplyChainandSalesChannelsAnalysis 12.1SupplyChainAnalysis 12.2SalesChannelsAnalysis
12.2.1HumanVaccineSalesChannels
12.2.2HumanVaccineDistributors
12.3HumanVaccineCustomers 13EstimatesandProjectionsbyRegions(2021-2027)
13.1GlobalHumanVaccineSalesForecast(2021-2027)
13.1.1GlobalHumanVaccineSalesForecastbyRegions(2021-2027)
13.1.2GlobalHumanVaccineRevenueForecastbyRegions(2021-2027) 13.2NorthAmericaMarketSizeForecast(2021-2027)
13.2.1NorthAmericaHumanVaccineSalesForecast(2021-2027)
13.2.2NorthAmericaHumanVaccineRevenueForecast(2021-2027)
13.2.3NorthAmericaHumanVaccineSizeForecastbyCounty(2021-2027) 13.3EuropeMarketSizeForecast(2021-2027)
13.3.1EuropeHumanVaccineSalesForecast(2021-2027)
13.3.2EuropeHumanVaccineRevenueForecast(2021-2027)
13.3.3EuropeHumanVaccineSizeForecastbyCounty(2021-2027) 13.4AsiaPacificMarketSizeForecast(2021-2027)
13.4.1AsiaPacificHumanVaccineSalesForecast(2021-2027)
13.4.2AsiaPacificHumanVaccineRevenueForecast(2021-2027)
13.4.3AsiaPacificHumanVaccineSizeForecastbyRegion(2021-2027) 13.5LatinAmericaMarketSizeForecast(2021-2027)
13.5.1LatinAmericaHumanVaccineSalesForecast(2021-2027)
13.5.2LatinAmericaHumanVaccineRevenueForecast(2021-2027)
13.5.3LatinAmericaHumanVaccineSizeForecastbyCounty(2021-2027) 13.6MiddleEastandAfricaMarketForecast
13.6.1MiddleEastandAfricaHumanVaccineSalesForecast(2021-2027)
13.6.2MiddleEastandAfricaHumanVaccineRevenueForecast(2021-2027)
13.6.3MiddleEastandAfricaHumanVaccineSizeForecastbyCounty(2021-2027) 14ResearchFindingsandConclusion 15Appendix
15.1ResearchMethodology
15.1.1Methodology/ResearchApproach
15.1.2DataSource
15.2AuthorDetails
15.3Disclaimer

Human Vaccine Market Segments


Human Vaccine Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Varicella
  • Influenza
  • Polio
  • Hepatitis A
  • Rabies
  • BCG
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Rota vaccine

Human Vaccine Application Outlook (Revenue, USD Million, 2021 2027)


  • Adults
  • Children

Human Vaccine Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

  • Europe
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

  • Asia Pacific
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

  • Latin America
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

  • Middle East & Africa
    • Human Vaccine market, By Product Type Outlook
      • Varicella
      • Influenza
      • Polio
      • Hepatitis A
      • Rabies
      • BCG
      • Hepatitis B
      • Pertussis, Diphtheria, Tetanus
      • Pneumococcal
      • Rota vaccine

    • Human Vaccine market, By Application Outlook
      • Adults
      • Children

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Tables
Table 1. Human Vaccine Key Market Segments
Table 2. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 3. Global Human Vaccine Market Size Growth Rate by Type 2021-2027 (M Doses) & (Million US$)
Table 4. Major Manufacturers of Varicella
Table 5. Major Manufacturers of Influenza
Table 6. Major Manufacturers of Polio
Table 7. Major Manufacturers of Hepatitis A
Table 8. Major Manufacturers of Rabies
Table 9. Major Manufacturers of BCG
Table 10. Major Manufacturers of Hepatitis B
Table 11. Major Manufacturers of Pertussis, Diphtheria, Tetanus
Table 12. Major Manufacturers of Pneumococcal
Table 13. Major Manufacturers of Rota vaccine
Table 14. Global Human Vaccine Market Share by Application 2020-2025 (M Doses)
Table 15. Global Human Vaccine Market Size by Regions 2016-2021 (M Doses) & (Million US$)
Table 16. Global Human Vaccine Sales by Regions 2016-2021 (M Doses)
Table 17. Global Human Vaccine Sales Market Share by Regions 2016-2021
Table 18. Global Human Vaccine Revenue by Regions 2016-2021 (Million US$)
Table 19. Global Human Vaccine Revenue Market Share by Regions 2016-2021
Table 20. Top Human Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2020
Table 21. Market Top Trends
Table 22. Human Vaccine Key Drivers: Impact Analysis (2021-2027)
Table 23. Human Vaccine Key Challenges
Table 24. Main Points Interviewed from Key Human Vaccine Players: Views for Future
Table 25. Global Human Vaccine Sales by Manufacturers (2016-2021) (M Doses)
Table 26. Global Human Vaccine Sales Share by Manufacturers (2016-2021)
Table 27. Human Vaccine Revenue by Manufacturers (2016-2021) (Million US$)
Table 28. Human Vaccine Revenue Share by Manufacturers (2016-2021)
Table 29. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2020)
Table 31. Key Manufacturers Human Vaccine Average Selling Price (ASP) (2016-2021) (USD/Dose)
Table 32. Key Manufacturers Human Vaccine Plants/Factories Distribution
Table 33. Key Manufacturers Human Vaccine Area Served
Table 34. Date of Key Manufacturers Enter into Human Vaccine Market
Table 35. Key Manufacturers Human Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Varicella Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 38. Global Influenza Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 39. Global Polio Sales ana Revenue (2016-2021) (M Doses) & (Million US$)
Table 40. Global Hepatitis A Sales ana Revenue (2016-2021) (M Doses) & (Million US$)
Table 41. Global Rabies Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 42. Global BCG Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 43. Global Hepatitis B Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 44. Global Pertussis, Diphtheria, Tetanus Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 45. Global Pneumococcal Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 46. Global Rota vaccine Sales and Revenue (2016-2021) (M Doses) & (Million US$)
Table 47. Global Human Vaccine Sales (M Doses) by Type (2016-2021)
Table 48. Global Human Vaccine Sales Share by Type (2016-2021)
Table 49. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 50. Global Human Vaccine Price (M Doses) by Type (2016-2021)
Table 51. Global Human Vaccine Sales (M Doses) by Type (2021-2027)
Table 52. Global Human Vaccine Sales Share by Type (2021-2027)
Table 53. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2021-2027)
Table 54. Global Human Vaccine Revenue Share by Type (2021-2027)
Table 55. Global Human Vaccine Price (M Doses) by Type (2021-2027)
Table 56. Global Human Vaccine Sales (M Doses) by Application (2016-2021)
Table 57. Global Human Vaccine Sales Share by Application (2016-2021)
Table 58. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 59. Global Human Vaccine Price by Application 2016-2021 (USD/Dose)
Table 60. Global Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 61. Global Human Vaccine Sales Share by Application (2016-2021)
Table 62. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2021-2027)
Table 63. Global Human Vaccine Revenue Share by Application (2021-2027)
Table 64. Global Human Vaccine Price (M Doses) by Application (2021-2027)
Table 65. North America Human Vaccine Sales by Company (2016-2021) (M Doses)
Table 66. North America Human Vaccine Sales Market Share by Company (2016-2021)
Table 67. North America Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 68. North America Human Vaccine Sales Market Share by Type (2016-2021)
Table 69. North America Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 70. North America Human Vaccine Sales Market Share by Application (2016-2021)
Table 71. North America Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 72. North America Human Vaccine Sales Market Share by Countries (2016-2021)
Table 73. North America Human Vaccine Revenue by Countries (2016-2021) (Million US$)
Table 74. North America Human Vaccine Revenue Market Share by Countries (2016-2021)
Table 75. Europe Human Vaccine Sales by Company (2016-2021) (M Doses)
Table 76. Europe Human Vaccine Sales Market Share by Company (2016-2021)
Table 77. Europe Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 78. Europe Human Vaccine Sales Market Share by Type (2016-2021)
Table 79. Europe Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 80. Europe Human Vaccine Sales Market Share by Application (2016-2021)
Table 81. Europe Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 82. Europe Human Vaccine Sales Market Share by Countries (2016-2021)
Table 83. Europe Human Vaccine Revenue by Countries (2016-2021) (Million US$)
Table 84. Europe Human Vaccine Revenue Market Share by Countries (2016-2021)
Table 85. Asia Pacific Human Vaccine Sales by Regions (2016-2021) (M Doses)
Table 86. Asia Pacific Human Vaccine Sales Market Share by Regions (2016-2021)
Table 87. Asia Pacific Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 88. Asia Pacific Human Vaccine Sales Market Share by Type (2016-2021)
Table 89. Asia Pacific Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 90. Asia Pacific Human Vaccine Sales Market Share by Application (2016-2021)
Table 91. Asia Pacific Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 92. Asia Pacific Human Vaccine Sales Market Share by Regions (2016-2021)
Table 93. Asia Pacific Human Vaccine Revenue by Regions (2016-2021) (Million US$)
Table 94. Asia Pacific Human Vaccine Revenue Market Share by Regions (2016-2021)
Table 95. Latin America Human Vaccine Sales by Company (2016-2021) (M Doses)
Table 96. Latin America Human Vaccine Sales Market Share by Company (2016-2021)
Table 97. Latin America Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 98. Latin America Human Vaccine Sales Market Share by Type (2016-2021)
Table 99. Latin America Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 100. Latin America Human Vaccine Sales Market Share by Application (2016-2021)
Table 101. Latin America Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 102. Latin America Human Vaccine Sales Market Share by Countries (2016-2021)
Table 103. Latin America Human Vaccine Revenue by Countries (2016-2021) (Million US$)
Table 104. Latin America Human Vaccine Revenue Market Share by Countries (2016-2021)
Table 105. Middle East and Africa Human Vaccine Sales by Type (2016-2021) (M Doses)
Table 106. Middle East and Africa Human Vaccine Sales Market Share by Type (2016-2021)
Table 107. Middle East and Africa Human Vaccine Sales by Application (2016-2021) (M Doses)
Table 108. Middle East and Africa Human Vaccine Sales Market Share by Application (2016-2021)
Table 109. Middle East and Africa Human Vaccine Sales by Countries (2016-2021) (M Doses)
Table 110. Middle East and Africa Human Vaccine Sales Market Share by Countries (2016-2021)
Table 111. Middle East and Africa Human Vaccine Revenue by Countries (2016-2021) (Million US$)
Table 112. Middle East and Africa Human Vaccine Revenue Market Share by Countries (2016-2021)
Table 113. CNBG Company Details
Table 114. CNBG Description and Business Overview
Table 115. CNBG Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. CNBG Human Vaccine Sales Growth Rate (2016-2021)
Table 117. CNBG Human Vaccine Sales Market Share in Global Market
Table 118. CNBG Recent Development
Table 119. Changsheng Life Company Details
Table 120. Changsheng Life Description and Business Overview
Table 121. Changsheng Life Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 122. Changsheng Life Human Vaccine Sales Growth Rate (2016-2021)
Table 123. Changsheng Life Human Vaccine Sales Market Share in Global Market
Table 124. Changsheng Life Recent Development
Table 125. Zhifei Company Details
Table 126. Zhifei Description and Business Overview
Table 127. Zhifei Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Zhifei Human Vaccine Sales Growth Rate (2016-2021)
Table 129. Zhifei Human Vaccine Sales Market Share in Global Market
Table 130. Zhifei Recent Development
Table 131. ChengDa Bio Company Details
Table 132. ChengDa Bio Description and Business Overview
Table 133. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 134. ChengDa Bio Human Vaccine Sales Growth Rate (2016-2021)
Table 135. ChengDa Bio Human Vaccine Sales Market Share in Global Market
Table 136. ChengDa Bio Recent Development
Table 137. Kangtai Company Details
Table 138. Kangtai Description and Business Overview
Table 139. Kangtai Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 140. Kangtai Human Vaccine Sales Growth Rate (2016-2021)
Table 141. Kangtai Human Vaccine Sales Market Share in Global Market
Table 142. Kangtai Recent Development
Table 143. SINOVAC BIOTECH Company Details
Table 144. SINOVAC BIOTECH Description and Business Overview
Table 145. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 146. SINOVAC BIOTECH Human Vaccine Sales Growth Rate (2016-2021)
Table 147. SINOVAC BIOTECH Human Vaccine Sales Market Share in Global Market
Table 148. SINOVAC BIOTECH Recent Development
Table 149. Hissen Company Details
Table 150. Hissen Description and Business Overview
Table 151. Hissen Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. Hissen Human Vaccine Sales Growth Rate (2016-2021)
Table 153. Hissen Human Vaccine Sales Market Share in Global Market
Table 154. Hissen Recent Development
Table 155. Walvax Biotechnology Company Details
Table 156. Walvax Biotechnology Description and Business Overview
Table 157. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Walvax Biotechnology Human Vaccine Sales Growth Rate (2016-2021)
Table 159. Walvax Biotechnology Human Vaccine Sales Market Share in Global Market
Table 160. Walvax Biotechnology Recent Development
Table 161. GSK Company Details
Table 162. GSK Description and Business Overview
Table 163. GSK Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 164. GSK Human Vaccine Sales Growth Rate (2016-2021)
Table 165. GSK Human Vaccine Sales Market Share in Global Market
Table 166. GSK Recent Development
Table 167. SANOFI Company Details
Table 168. SANOFI Description and Business Overview
Table 169. SANOFI Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 170. SANOFI Human Vaccine Sales Growth Rate (2016-2021)
Table 171. SANOFI Human Vaccine Sales Market Share in Global Market
Table 172. SANOFI Recent Development
Table 173. Rong An Company Details
Table 174. Rong An Description and Business Overview
Table 175. Rong An Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 176. Rong An Human Vaccine Sales Growth Rate (2016-2021)
Table 177. Rong An Human Vaccine Sales Market Share in Global Market
Table 178. Rong An Recent Development
Table 179. NuoCheng Bio Company Details
Table 180. NuoCheng Bio Description and Business Overview
Table 181. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 182. NuoCheng Bio Human Vaccine Sales Growth Rate (2016-2021)
Table 183. NuoCheng Bio Human Vaccine Sales Market Share in Global Market
Table 184. NuoCheng Bio Recent Development
Table 185. Hualan Bio Company Details
Table 186. Hualan Bio Description and Business Overview
Table 187. Hualan Bio Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 188. Hualan Bio Human Vaccine Sales Growth Rate (2016-2021)
Table 189. Hualan Bio Human Vaccine Sales Market Share in Global Market
Table 190. Hualan Bio Recent Development
Table 191. Tiantan biological Company Details
Table 192. Tiantan biological Description and Business Overview
Table 193. Tiantan biological Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 194. Tiantan biological Human Vaccine Sales Growth Rate (2016-2021)
Table 195. Tiantan biological Human Vaccine Sales Market Share in Global Market
Table 196. Tiantan biological Recent Development
Table 197. Changchun Baike Company Details
Table 198. Changchun Baike Description and Business Overview
Table 199. Changchun Baike Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 200. Changchun Baike Human Vaccine Sales Growth Rate (2016-2021)
Table 201. Changchun Baike Human Vaccine Sales Market Share in Global Market
Table 202. Changchun Baike Recent Development
Table 203. Adimmune Company Details
Table 204. Adimmune Description and Business Overview
Table 205. Adimmune Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 206. Adimmune Human Vaccine Sales Growth Rate (2016-2021)
Table 207. Adimmune Human Vaccine Sales Market Share in Global Market
Table 208. Adimmune Recent Development
Table 209. Zhongyianke Biotech Company Details
Table 210. Zhongyianke Biotech Description and Business Overview
Table 211. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 212. Zhongyianke Biotech Human Vaccine Sales Growth Rate (2016-2021)
Table 213. Zhongyianke Biotech Human Vaccine Sales Market Share in Global Market
Table 214. Zhongyianke Biotech Recent Development
Table 215. Human Vaccine Distributors List
Table 216. Human Vaccine Customers List
Table 217. Global Human Vaccine Sales Forecast 2021-2027 (M Doses) & (Million US$)
Table 218. Global Human Vaccine Sales Forecast by Type 2021-2027 (M Doses)
Table 219. Global Human Vaccine Sales Forecast by Application 2021-2027 (M Doses)
Table 220. Global Human Vaccine Sales Forecast by Regions 2021-2027 (M Doses)
Table 221. Global Human Vaccine Revenue Forecast by Regions 2021-2027 (Million US$)
Table 222. North America Human Vaccine Sales Forecast by Countries 2021-2027 (M Doses)
Table 223. North America Human Vaccine Revenue Forecast by Countries 2021-2027
Table 224. Europe Human Vaccine Sales Forecast by Countries 2021-2027 (M Doses)
Table 225. Europe Human Vaccine Revenue Market Share Forecast by Countries 2021-2027
Table 226. Asia Pacific Human Vaccine Sales Forecast by Regions 2021-2027 (M Doses)
Table 227. Asia Pacific Human Vaccine Revenue Forecast by Regions 2021-2027 (Million US$)
Table 228. Latin America Human Vaccine Sales Forecast by Countries 2021-2027 (M Doses)
Table 229. Latin America Human Vaccine Revenue Forecast by Countries 2021-2027 (Million US$)
Table 230. Middle East and Africa Human Vaccine Sales Forecast by Regions 2021-2027 (M Doses)
Table 231. Middle East and Africa Human Vaccine Revenue Forecast by Regions 2021-2027 (Million US$)
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Vaccine Product Picture
Figure 2. Global Human Vaccine Sales Market Shar by Type 2016-2027
Figure 3. Varicella Figures
Figure 4. Influenza Figures
Figure 5. Polio Figures
Figure 6. Hepatitis A Figures
Figure 7. Rabies Figures
Figure 8. BCG Figures
Figure 9. Hepatitis B Figures
Figure 10. Pertussis, Diphtheria, Tetanus Figures
Figure 11. Pneumococcal Figures
Figure 12. Global Human Vaccine Sales Market Share by Application in 2020 & 2027
Figure 13. Adults Use Case
Figure 14. Children Use Case
Figure 15. Human Vaccine Report Years Considered
Figure 16. Global Human Vaccine Market Size 2016-2027 (Million US$)
Figure 17. Global Human Vaccine Sales 2016-2021 (M Doses)
Figure 18. Global Human Vaccine Market Size Market Share by Regions 2016-2021
Figure 19. Global Human Vaccine Sales Market Share by Regions in 2020
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Human Vaccine Sales Share by Manufacturers in 2020
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Vaccine Sales in 2020
Figure 23. Human Vaccine Value Share by Manufacturers in 2020
Figure 24. Human Vaccine Revenue Share by Manufacturers In 2020
Figure 25. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Human Vaccine Revenue Share by Type (2016-2021)
Figure 27. Global Human Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 28. Global Human Vaccine Market Share by Price Range (2016-2021)
Figure 29. Global Human Vaccine Revenue Share by Application (2016-2021)
Figure 30. Global Human Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 31. North America Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 32. U.S. Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 33. Canada Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 34. Europe Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 35. Germany Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 36. France Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 37. U.K. Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 38. Italy Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 39. Russia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 40. Asia Pacific Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 41. China Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 42. Japan Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 43. South Korea Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 44. India Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 45. Australia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 46. Taiwan Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 47. Indonesia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 48. Thailand Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 49. Malaysia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 50. Philippines Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 51. Vietnam Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 52. Latin America Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 53. Mexico Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 54. Brazil Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 55. Argentina Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 56. Middle East and Africa Human Vaccine Revenue Growth Rate 2016-2021 (Million US$)
Figure 57. Turkey Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 58. Saudi Arabia Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 59. U.A.E Human Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 60. CNBG Total Revenue (US$ Million): 2020 Compared with 2018
Figure 61. Changsheng Life Total Revenue (US$ Million): 2020 Compared with 2018
Figure 62. Zhifei Total Revenue (US$ Million): 2020 Compared with 2018
Figure 63. ChengDa Bio Total Revenue (US$ Million): 2020 Compared with 2018
Figure 64. Kangtai Total Revenue (US$ Million): 2020 Compared with 2018
Figure 65. SINOVAC BIOTECH Total Revenue (US$ Million): 2020 Compared with 2018
Figure 66. Hissen Total Revenue (US$ Million): 2020 Compared with 2018
Figure 67. Walvax Biotechnology Total Revenue (US$ Million): 2020 Compared with 2018
Figure 68. GSK Total Revenue (US$ Million): 2020 Compared with 2018
Figure 69. SANOFI Total Revenue (US$ Million): 2020 Compared with 2018
Figure 70. Rong An Total Revenue (US$ Million): 2020 Compared with 2018
Figure 71. NuoCheng Bio Total Revenue (US$ Million): 2020 Compared with 2018
Figure 72. Hualan Bio Total Revenue (US$ Million): 2020 Compared with 2018
Figure 73. Tiantan biological Total Revenue (US$ Million): 2020 Compared with 2018
Figure 74. Changchun Baike Total Revenue (US$ Million): 2020 Compared with 2018
Figure 75. Adimmune Total Revenue (US$ Million): 2020 Compared with 2018
Figure 76. Zhongyianke Biotech Total Revenue (US$ Million): 2020 Compared with 2018
Figure 77. Human Vaccine Value Chain
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. North America Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 81. North America Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 82. Europe Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 83. Europe Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 84. Asia Pacific Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 85. Asia Pacific Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 86. Latin America Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 87. Latin America Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 88. Middle East and Africa Human Vaccine Sales Growth Rate Forecast (2021-2027) (M Doses)
Figure 89. Middle East and Africa Human Vaccine Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Antibody Drug Conjugates Contract Manufacturing Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Therapeutic Drug Monitoring Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Topical Drug Delivery System Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More